On March 16, 2009, Air Force veteran Jorge Ortiz and his wife welcomed their new baby daughter after a harrowing delivery at Evans Army Community Hospital in Colorado, where the mother was an active duty Air Force Captain. The childbirth – a planned C-section delivery... Read More

In late October, an Illinois man sued Invokana manufacturers Jannsen Pharmaceuticals, Inc., Johnson & Johnson Co., and Mitsubishi Tanaba Pharma Corp. over injuries allegedly caused by the drug. The Invokana lawsuit seeks more than $75,000 in compensation and alleges a number of claims including product liability, defective... Read More

The United States has been named as a defendant in a new birth injury lawsuit, which was recently filed in the United States District Court for the Southern District of West Virginia. The lawsuit was filed on behalf of a West Virginia mother and her... Read More

An increasing number of patients have begun to file IVC filter lawsuits in the federal court system against C.R. Bard and Cook Medical, claiming the devices have the potential to migrate. Plaintiffs claim when these small metal devices drift, they can puncture the vena cava... Read More

A member of congress has sent a letter to the FDA requesting that the organization investigate whether three hospitals violated mandatory reporting policies in connection deaths related to the use of power morcellators during gynecological surgery. Michael G. Fitzpatrick, representative of the 8th district of... Read More

A Missouri couple has filed a birth injury lawsuit against the two OB/GYNs who delivered their son. The parents claim the negligent behavior of the doctors caused their child to be born with debilitating birth defects he will have for the rest of his life.... Read More

The fourth Risperdal trial to date has resulted in a $500,000 award for the plaintiff. It took just six hours of deliberations for the Philadelphia jury to find in favor of the plaintiff in the case of Timothy Stange v. Janssen Pharmaceuticals. Calling the verdict “another... Read More

One of the newer generations of diabetes medications, Invokana, has come under fire in recent months for potentially increasing the risk of serious health problems. Now, the FDA has issued a new safety communication informing healthcare practitioners and patients that the agency has revised labeling information... Read More